2013
DOI: 10.1177/0961203313483377
|View full text |Cite
|
Sign up to set email alerts
|

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE)

Abstract: HMGB1 release is increased in the skin of SLE patients compared to HCs. Upon UVB exposure, HMGB1 release further increases in SLE patients and is related to the number of apoptotic cells. Our data suggest that HMGB1, probably released from apoptotic keratinocytes, contributes to the development of inflammatory lesions in the skin of SLE patients upon UVB exposure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0
1

Year Published

2014
2014
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 32 publications
0
20
0
1
Order By: Relevance
“…Melinda Magna 1 and David S Pisetsky of characteristic tissue pathology (for example, arthritis) or functional disturbance (for example, muscle weakness in myositis) by HMGB1 in in vitro or in vivo models; and (d) effectiveness of agents directed at HMGB1 in animal models (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). Table 1 lists diseases in which studies implicate a role of HMGB1 in pathogenesis.…”
Section: The Role Of Hmgb1 In the Pathogenesis Of Inflammatory And Aumentioning
confidence: 99%
“…Melinda Magna 1 and David S Pisetsky of characteristic tissue pathology (for example, arthritis) or functional disturbance (for example, muscle weakness in myositis) by HMGB1 in in vitro or in vivo models; and (d) effectiveness of agents directed at HMGB1 in animal models (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). Table 1 lists diseases in which studies implicate a role of HMGB1 in pathogenesis.…”
Section: The Role Of Hmgb1 In the Pathogenesis Of Inflammatory And Aumentioning
confidence: 99%
“…HMGB1 can be passively released by necrotic or damaged cells [13] and can be detected in serum samples as a biomarker [14,15]. SSE can lead to HMGB1 release from injured cells into blood circulation [16], and cytoplasmic translocation has been detected in lung tissues from SSE-exposed rats [17] release is increased in the skin of SLE patients compared to healthy controls, and HMGB1 release contributes to the development of inflammatory skin lesions [18]. Ultraviolet (UV) irradiation induces an inflammatory skin response that is initiated by HMGB1 release from UV-damaged keratinocytes [19].…”
Section: Introductionmentioning
confidence: 99%
“…Nucleosomes containing HMGB1, detected in the serum of SLE patients, led to production of inflammatory cytokines IL-6, IL1β, and TNF-α coupled to DC activation in a TLR-2 dependent manner (43). SLE patients with inflammatory skin lesions release HMGB1 at the lesion site upon exposure to UVB exposure (44). As a whole, reports show that HMGB1 is considered a potent inflammatory mediator in acute settings when associated with autoimmune disease.…”
Section: Discussionmentioning
confidence: 99%